贝伐单抗在肿瘤治疗中的药物遗传学：仍在寻找拼图的正确拼块。 - Suppr

Suppr

超能文献

Bevacizumab pharmacogenetics in tumor treatment: still looking for the right pieces of the puzzle.

作者信息

Bocci Guido, Loupakis Fotios

出版信息

Pharmacogenomics. 2011 Aug;12(8):1077-80. doi: 10.2217/pgs.11.75.

DOI:10.2217/pgs.11.75

PMID:21843059

Abstract

摘要

相似文献

Bevacizumab pharmacogenetics in tumor treatment: still looking for the right pieces of the puzzle.

Pharmacogenomics. 2011 Aug;12(8):1077-80. doi: 10.2217/pgs.11.75.

Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies.

Cancer J. 2008 May-Jun;14(3):170-7. doi: 10.1097/PPO.0b013e318178d9de.

A new weapon for attacking tumor blood vessels.

N Engl J Med. 2008 May 8;358(19):2066-7. doi: 10.1056/NEJMcibr0800272.

[New medications; bevacizumab].

Ned Tijdschr Geneeskd. 2006 Oct 7;150(40):2194-5.

Hoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors.

Acta Oncol. 2009;48(8):1213-5. doi: 10.3109/02841860902980453.

[Anti-angiogenetic agents for solid tumors].

Rev Med Interne. 2007 Jun;28 Suppl 1:S7-8. doi: 10.1016/j.revmed.2007.03.021. Epub 2007 Apr 20.

Regression of neovascular iris vessels by intravitreal injection of bevacizumab.

Retina. 2006 Sep;26(7):839-41. doi: 10.1097/01.iae.0000230425.31296.3b.

Bevacizumab for advanced breast cancer.

Hematol Oncol Clin North Am. 2007 Apr;21(2):303-19. doi: 10.1016/j.hoc.2007.03.006.

Antiangiogenic agents in breast cancer.

Cancer Invest. 2007 Oct;25(7):518-26. doi: 10.1080/07357900701648516.

Current overview of angiogenesis inhibitors.

Clin Adv Hematol Oncol. 2004 Aug;2(8):494-6, 520.

引用本文的文献

Pharmacogenetics of anticancer monoclonal antibodies.

Cancer Drug Resist. 2019 Mar 19;2(1):69-81. doi: 10.20517/cdr.2018.20. eCollection 2019.

A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients.

NPJ Breast Cancer. 2022 Mar 21;8(1):33. doi: 10.1038/s41523-022-00400-6.

Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy.

Mol Neurobiol. 2018 Feb;55(2):1396-1404. doi: 10.1007/s12035-017-0414-9. Epub 2017 Feb 1.

Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer.

Pharmacogenomics J. 2015 Feb;15(1):69-76. doi: 10.1038/tpj.2014.40. Epub 2014 Jul 29.

Prospective validation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab.

PLoS One. 2013 Jul 4;8(7):e66774. doi: 10.1371/journal.pone.0066774. Print 2013.

VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide.

Br J Cancer. 2013 Aug 20;109(4):957-64. doi: 10.1038/bjc.2013.398. Epub 2013 Jul 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验